Previous 10 | Next 10 |
Camber Energy (NYSEMKT: CEI ) +53% . More news on: Camber Energy, Inc., Wright Medical Group N.V., Enlivex Therapeutics Ltd., Stocks on the move, Read more ...
Acorda Therapeutics (NASDAQ: ACOR ) is scheduled to announce Q3 earnings results on Monday, November 4th, after market close. The consensus EPS Estimate is -$0.51 vs. $0.17 in 3Q18 and the consensus Revenue Estimate is $44.38M (-68.9% Y/Y). Over the last 2 years, acor has be...
AAN , ACOR , ADUS , AOSL , APLE , APTS , AWR , BHF , BKD , BKH , BWXT , CBT , CC , CDE , CDEV , CHGG , CPE , DIOD , DK , DOOR , ED , ETH , EVBG , EVER , FICO , FN , FRPT , FRTA , FTSI , GRPN , HHC , HIG , HLIO , HPR , HR , HTZ , IFF , ITRI , JKHY , KA...
Gainers: Rexahn Pharmaceuticals (NASDAQ: REXN ) +45% . California Resources Corporation (NYSE: CRC ) +40% . BeiGene (NASDAQ: BGNE ) +34% . El Pollo Loco Holdings (NASDAQ: LOCO ) +28% . Acorda Therapeutics (NASDAQ: ACOR ) +26% . American Axle & Manufacturing Holdings (NYSE: A...
Acorda Therapeutics ( ACOR ) pre-announced Q3 sales of Inbrija and Ampyra along with a restructuring plan. I wrote about the company in July before the company announced Q2 results, and I warned of the difficulties of a new launch and that caution is warranted. The situation has not im...
Gainers: Lightbridge Corporation (NASDAQ: LTBR ) +19% . Sesen Bio (NASDAQ: SESN ) +17% . Visteon Corporation (NASDAQ: VC ) +17% . Tesla (NASDAQ: TSLA ) +17% . Rigel Pharmaceuticals (NASDAQ: RIGL ) +17% . TrovaGene (NASDAQ: TROV ) +16% . Contango Oil & Gas Company (NYSEMKT: ...
OpGen (NASDAQ: OPGN ) -55% on pricing equity offering. More news on: OpGen, Inc., Nokia Corporation, Twitter, Inc., Stocks on the move, Read more ...
ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Market Perform rating and $44 (5% upside) price target at Oppenheimer. More news on: ACADIA Pharmaceuticals Inc., Nektar Therapeutics, Neovasc Inc., Healthcare stocks news, Stocks on the move, , Read more ...
Total non-GAAP operating expenses for the full year 2020 expected to be $180 - $190 million 1 Estimated 2020 operating expenses reduced by ~$60 million compared to 2019 revised guidance - Includes more than $21 million in expected annualized cost savings from headcount reduction ...
“Do Tell” Your Doctor Tool was adapted from a clinically validated questionnaire developed by Duke University, with input from the Parkinson’s community Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced the launch of the “Do Tell” Your Doctor...
News, Short Squeeze, Breakout and More Instantly...
Acorda Therapeutics Inc. Company Name:
ACOR Stock Symbol:
NASDAQ Market:
Acorda Therapeutics Inc. Website:
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 11.3% to $0.2025 on volume of 40,515,259 shares Rallybio Corporation (RLYB) rose 80.4% to $2.9401 on volume of 39,492,767 shares Trio Petroleum Corp. (TPET) rose 36.3% to $0.2499 on volume of 3...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 28.8% to $0.0515 on volume of 62,068,605 shares Laser Photonics Corporation (LASE) rose 172.7% to $3.9 on volume of 54,588,758 shares WiSA Technologies Inc. (WISA) fell 6.1% to $0.0217 on volume of 2...
Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective with the opening of business on April 12, 2024. The notice follows the Company's April 1, 2024 announc...